An update on the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design

被引：72

作者：

Califf, Robert M. ^{[1
]}

Lokhnygina, Yuliya ^{[2
]}

Cannon, Christopher P. ^{[3
]}

Stepanavage, Michael E. ^{[4
]}

McCabe, Carolyn H. ^{[3
]}

Musliner, Thomas A. ^{[5
]}

Pasternak, Richard C. ^{[5
]}

Blazing, Michael A. ^{[2
]}

Giugliano, Robert P. ^{[3
]}

Harrington, Robert A. ^{[2
]}

Braunwald, Eugene ^{[3
]}

机构：

[1] Duke Univ, Duke Translat Med Inst, Durham, NC 27706 USA

[2] Duke Univ, Duke Clin Res Inst, Durham, NC USA

[3] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA

[4] Merck & Co Inc, Rahway, NJ 07065 USA

[5] Merck & Co Inc, N Wales, PA USA

来源：

AMERICAN HEART JOURNAL | 2010年 / 159卷 / 05期

关键词：

CARDIOVASCULAR OUTCOMES; EZETIMIBE; SIMVASTATIN; ATHEROSCLEROSIS; CANCER; NIACIN;

D O I：

10.1016/j.ahj.2010.03.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：705 / 709

页数：5

共 24 条

[11] Cardiovascular and metabolic risk factors: How can we improve outcomes in the high-risk patient? Discussion following Dr. Grundy's presentation
Grundy, Scott M.
[J]. AMERICAN JOURNAL OF MEDICINE, 2007, 120 (09) : 9 - 9
[12] Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
[13] Simvastatin with or without ezetimibe in familial hypercholesterolemia
Kastelein, John J. P.
Akdim, Fatima
Stroes, Erik S. G.
Zwinderman, Aeilko H.
Bots, Michiel L.
Stalenhoef, Anton F. H.
Visseren, Frank L. J.
Sijbrands, Eric J. G.
Trip, Mieke D.
Stein, Evan A.
Gaudet, Daniel
Duivenvoorden, Raphael
Veltri, Enrico P.
Marais, A. David
de Groot, Eric
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14) : 1431 - 1443
[14] Statin Therapy with Ezetimibe or Niacin in High-Risk Patients
Kastelein, John J. P.
Bots, Michiel L.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (22) : 2180 - 2183
[15] Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
Lee, Justin M. S.
Robson, Matthew D.
Yu, Ly-Mee
Shirodaria, Cheerag C.
Cunnington, Colin
Kylintireas, Ilias
Digby, Janet E.
Bannister, Thomas
Handa, Ashok
Wiesmann, Frank
Durrington, Paul N.
Channon, Keith M.
Neubauer, Stefan
Choudhury, Robin P.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (19) : 1787 - 1794
[16] MULTIPLE TESTING PROCEDURE FOR CLINICAL-TRIALS
OBRIEN, PC
FLEMING, TR
[J]. BIOMETRICS, 1979, 35 (03) : 549 - 556
[17] ORIORDAN M, 2008, HEARTWIRE 0328
[18] Analyses of cancer data from three Ezetimibe trials
Peto, Richard
Emberson, Jonathan
Landray, Martin
Baigent, Colin
Collins, Rory
Clare, Robert
Califf, Robert
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) : 1357 - 1366
[19] Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
Rossebo, Anne B.
Pedersen, Terje R.
Boman, Kurt
Brudi, Philippe
Chambers, John B.
Egstrup, Kenneth
Gerdts, Eva
Gohlke-Barwolf, Christa
Holme, Ingar
Kesaniemi, Y. Antero
Malbecq, William
Nienaber, Christoph A.
Ray, Simon
Skjaerpe, Terje
Wachtell, Kristian
Willenheimer, Ronnie
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) : 1343 - 1356
[20] Prognostic value of the admission electrocardiogram in acute coronary syndromes
Savonitto, S
Ardissino, D
Granger, CB
Morando, G
Prando, MD
Mafrici, A
Cavallini, C
Melandri, G
Thompson, TD
Vahanian, A
Ohman, EM
Califf, RM
Van de Werf, F
Topol, EJ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (08): : 707 - 713

← 1 2 3 →